Vivid Dx - About the company
Vivid Dx is an unfunded company based in Oxford (United Kingdom), founded in 2022 by Jeff Liu. It operates as a Developer of diagnostic platform for rapid detection of sepsis-causing pathogens. Vivid Dx has not raised any funding yet. The company has 115 active competitors, including 35 funded and 14 that have exited. Its top competitors include companies like OpGen, Volition and Verax Biomedical.
Company Details
Developer of diagnostic platform for rapid detection of sepsis-causing pathogens. It is developing a platform that uses Raman spectroscopy to read biochemical fingerprints. The platform detects sepsis-causing pathogens using a Raman spectra database. Advanced artificial intelligence and machine learning are used to accelerate detection.
Key Metrics
Founded Year
2022
Location
Oxford, United Kingdom
Stage
Unfunded
Ranked
48th among 115 active competitors
Sign up to download Vivid Dx's company profile
Vivid Dx's funding and investors
Vivid Dx has not raised any funding rounds yet.
Vivid Dx's founders and board of directors
Founder? Claim ProfileThe founders of Vivid Dx is Jeff Liu.
Here are the details of Vivid Dx's key team members:
- Jeff Liu: Founder & CTO of Vivid Dx.
View details of Vivid Dx's Founder profiles and Board Members
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Vivid Dx's Competitors and alternates
Top competitors of Vivid Dx include OpGen, Volition and Verax Biomedical. Here is the list of Top 10 competitors of Vivid Dx, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  OpGen 2002, Rockville (United States), Public | Developer of diagnostics and bioinformatics platforms for providers | $77.5M | 65/100 | |
2nd | Developer of cancer diagnostic tests | - | 57/100 | ||
3rd | Verax Biomedical 1999, Marlborough (United States), Series D | Rapid bacterial detection tests for safer platelet transfusions and cell therapies | $72.3M | 56/100 | |
4th | Accelerate Diagnostics 1987, Tucson (United States), Public | Developer of diagnostic devices and test kits for the antibiotic resistant infections | - | - | 54/100 |
5th | CytoVale 2013, San Francisco (United States), Series D | Microfluidic-based biomarkers for the early detection of sepsis | $207M | 51/100 | |
6th | DNA Electronics 2003, London (United Kingdom), Series C | Provider of semi-conductor-based NGS diagnostics for infectious diseases | - | 51/100 | |
7th | Bluejay Diagnostics 2015, Acton (United States), Public | Non-invasive point-of-care diagnostic solutions | $3.73M | 50/100 | |
8th |  SphingoTec 2002, Hennigsdorf (Germany), Series C | Developer of biomarker-based diagnostic solutions for cancer, cardiovascular, and other diseases | $36.1M | 50/100 | |
9th |  Abionic 2010, Epalinges (Switzerland), Series C | Provider of point-of-care diagnostic tool for allergy profiles | $28.9M | 49/100 | |
10th | Avails Medical 2013, Menlo Park (United States), Series A | Rapid AST technology for faster, actionable results in bloodstream infections | $8.66M | 48/100 | |
48th |  Vivid Dx 2022, Oxford (United Kingdom), Unfunded | Developer of diagnostic platform for rapid detection of sepsis-causing pathogens | - | - | 30/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Vivid Dx's competitors? Click here to see the top ones
Vivid Dx's Investments and acquisitions
Vivid Dx has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about Vivid Dx
Explore our recently published companies
- Medwell360 - 2025 founded, Unfunded company
- Kaizen - Unfunded company
- Ford Country - Henderson based, 1996 founded, Unfunded company
- A2Z Creations - Panipat based, 2015 founded, Unfunded company
- IRG Commercial - Altamonte Springs based, 1989 founded, Unfunded company
- GMR Quality Stone Products - Sterling Heights based, 2002 founded, Unfunded company
